Skip to main content

Prototype Prescribing Outlier Dashboard for Lmn PCN

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all PCNs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given PCN is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all PCN's chemical:subparagraph ratios is provided, with this PCN's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Lmn PCN is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Paraffin soft white 13 Emollients 551 0.02 0.00 0.00 9.33
Other topical corticosteroid preparations 4 Topical corticosteroids 2,132 0.00 0.00 0.00 8.17
Orphenadrine hydrochloride 8 Antimuscarinic drugs used in parkinsonism 61 0.13 0.01 0.02 7.62
Undecenoates 9 Antifungal preparations 323 0.03 0.00 0.00 7.54
Strontium ranelate 9 Bisphosphonates and other drugs 2,089 0.00 0.00 0.00 4.99
Loteprednol etabonate 31 Corticosteroids 215 0.14 0.02 0.03 4.73
Alendronic acid/colecalciferol 18 Bisphosphonates and other drugs 2,089 0.01 0.00 0.00 4.42
Etoricoxib 480 Non-steroidal anti-inflammatory drugs 2,710 0.18 0.04 0.03 4.32
Mometasone furoate 7 Corticosteroids (respiratory) 5,015 0.00 0.00 0.00 4.28
Minocycline hydrochloride 34 Tetracyclines 1,401 0.02 0.00 0.00 4.14

Prescribing where Lmn PCN is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Procyclidine hydrochloride 27 Antimuscarinic drugs used in parkinsonism 61 0.44 0.85 0.11 -3.80
Doxazosin mesilate 1,424 Alpha-adrenoceptor blocking drugs 1,497 0.95 0.99 0.01 -3.70
Oral rehydration salts 11 Oral sodium and water 120 0.09 0.65 0.20 -2.84
Beclometasone dipropionate 1,598 Corticosteroids (respiratory) 5,015 0.32 0.57 0.09 -2.71
Sertraline hydrochloride 3,431 Selective serotonin re-uptake inhibitors 10,994 0.31 0.46 0.06 -2.64
Glucose 46 Treatment of hypoglycaemia 83 0.55 0.77 0.09 -2.44
Sildenafil (Erectile Dysfunction) 896 Drugs for erectile dysfunction 1,391 0.64 0.76 0.05 -2.23
Levonorgestrel 2 Emergency contraception 8 0.25 0.60 0.16 -2.18
Rifampicin 0 Antituberculosis drugs 5 0.00 0.74 0.34 -2.17
    Zinc oxide 16 Soothing haemorrhoidal preparations 32 0.50 0.78 0.13 -2.12